RAD Technology Medical Systems provides complex, design-built modular facilities for the healthcare industry. #ASTRO #ASTRO21

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting. The 2021 annual meeting is being held at McCormick Place in Chicago, IL, Oct.24-27, 2021.  

While at ASTRO, RAD will be promoting their mission of consistently providing radiotherapy facilities that meet their clients' vision and desire to provide advanced, high quality radiotherapy treatment for their patients.

RAD uses offsite construction methods and their proprietary shielding to construct radiotherapy facilities that can be completed up to 50% faster than traditional construction. In addition, their radiotherapy facilities are flexible and able to adapt to changing technology and facility requirements. Stop by booth 1113 to learn about RAD's modular radiotherapy products.

The RAD Temp is a temporary radiotherapy facility that allows you to continue treating patients while you upgrade the equipment in your current vault. 

RAD Centers are a combination of proprietary and customized modular vault technology and clinical space. RAD will design and build a cancer center that meets all of your individual program needs.

Fitted with RAD's removable linac base frames, our vaults allow clients to easily swap accelerators from different vendors without saw cutting or excessive downtime. Our platforms easily adapt to accommodate new equipment as technology advances, and we can add or remove whole modules as necessary should your program needs change. In addition, if market conditions change, entire facilities can be removed and/or relocated.

"We are excited to be back in person at ASTRO this year," said Kenneth Wright, Vice President of Sales and Business Development. "We are looking forward to connecting with previous, current and new customers." 

For more information: www.radtechnology.com


Related Content

News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Subscribe Now